Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies
Age-related macular degeneration (AMD) is a neurodegenerative disease of the aging retina, in which patients experience severe vision loss. Therapies available to patients are limited and are only effective in a sub-population of patients. Future comprehensive clinical care depends on identifying ne...
Main Authors: | Majda Hadziahmetovic, Goldis Malek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2020.612812/full |
Similar Items
-
Autologous full-thickness RPE-choroid graft to treat high-risk drusenoid pigment epithelial detachment without CNV
by: Sillen, Hedwig, et al.
Published: (2020-04-01) -
Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration
by: Aihua Liu, et al.
Published: (2010-11-01) -
Interleukin-13 and age-related macular degeneration
by: Bo Fu, et al.
Published: (2017-04-01) -
Treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration
by: Andres Gonzalez, et al.
Published: (2018-03-01) -
Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function
by: Maria C. Savastano, et al.
Published: (2020-09-01)